Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 February 2021 | Story Leonie Bolleurs | Photo istock
The Faculty of Natural and Agricultural Sciences has reorganised three of its departments, and as a result the Departments of Animal Science, Microbiology and Biochemistry, and Sustainable Food Systems and Development have been established.

In a continuous effort to inspire excellence and transform lives, the Faculty of Natural and Agricultural Sciences at the University of the Free State (UFS) has reorganised three of its departments. The entities that were affected include what was known as the Department of Consumer Science; the Department of Animal, Wildlife and Grassland Sciences; and the Division of Food Science.

The Department of Animal, Wildlife and Grassland Sciences has changed to Animal Science, while the Department of Consumer Science and the Centre for Sustainable Agriculture, Rural Development, and Extension (CENSARDE) merged to become the Department of Sustainable Food Systems and Development.

Sustainable food systems

Both the Department of Consumer Science and CENSARDE are major contributors to studies on food systems. According to Prof Johan van Niekerk, Head of the new Department of Sustainable Food Systems and Development, the two academic entities create a natural link that provides the potential for training, development, and research from a food systems perspective to benefit the local and national agri-business sector. 

Prof van Niekerk elaborates: “Food systems can be defined as the processes involved in providing food, fibre, and fuel products. These processes include growing, harvesting, processing, preparing, packaging, transporting, marketing, consumption, and waste management.”

“In terms of the academic structure at the UFS, the processing, preparing, and packaging of food resided within the Department of Consumer Sciences. The processes of growing, harvesting and food production, on the other hand, resided within the Centre for Sustainable Agriculture. The newly established Department of Sustainable Food Systems and Development holds the potential to combine the academic expertise of two separate entities into an interdisciplinary body that focuses on sustainable food systems from a holistic perspective.”

Relevant on a global scale

According to Prof Frikkie Neser, Head of the now Department of Animal Science, it is a worldwide phenomenon that Animal Science and all its related disciplines are classified under the name Animal Science.

As part of the changes in this discipline, Meat Science, Dairy Science, and Wool Science will again be presented within the department. Meat scientist, Prof Arno Hugo, and dairy scientist, Dr Koos Myburgh, and their support staff also joined the department. 

According to Prof Neser, the changes will also lead to the establishment of a Meat and Dairy Unit, an Animal Breeding Genomics and Bioinformatics Unit (ABGB), and a Dairy Processing Unit. The latter will be hosted on the Paradys Experimental Farm outside Bloemfontein.

Prof Neser says that changes to the department will simplify the curriculum without compromising the quality of the content or the professional registration of Animal Science students.

“Students will be exposed to the full value chain in meat, dairy, and wool, and research and product development can be conducted in our own fully equipped facilities,” says Prof Neser.

The changes will also lead to a better service to the industry. “Quality as well as chemical and microbial composition of meat will be tested for the whole meat industry. A similar service will also be provided for the dairy industry,” he says.

“A consulting service will also be available,” adds Prof Neser.

Furthermore, he says that the ABGB Unit will provide a statistical and analytical service to the university and the industry. “With the unit, it is possible to create a research facility that can coordinate and enhance all animal breeding research in the country, which will help South Africa to remain relevant on a global scale.”

As much as it will have a global footprint, the department will also add value on a local basis by presenting short courses in all disciplines for both commercial and emerging farmers, as well as the community as a whole.

“We will also continue to build on relationships with other universities, research and government institutions,” says Prof Neser.

Changes to Division of Food Science 

Another significant change that took place in the faculty was in the Division of Food Science. With the changes taking place in the Division of Food Science, the Department of Microbial, Biochemical and Food Biotechnology is now known as the Department of Microbiology and Biochemistry.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept